203340-07-2

Basic information

• Product Name: 1H-Tetrazole, 5-(4-chloro-3-nitrophenyl)-
• CAS NO: 203340-07-2
• Molecular Formula: C7H4ClN5O2
• Molecular Weight: 225.594
• Mol File: 203340-07-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1H-Tetrazole, 5-(4-chloro-3-nitrophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Tetrazole, 5-(4-chloro-3-nitrophenyl)-(203340-07-2)
• EPA Substance Registry System: 1H-Tetrazole, 5-(4-chloro-3-nitrophenyl)-(203340-07-2)

Safety Data

• Hazardous Substances Data: 203340-07-2(Hazardous Substances Data)

Upstream product

• 16588-34-4 4-chloro-3-nitro-benzaldehyde 
• 16687-61-9 5-(4-chlorophenyl)-1H-tetrazole 

Downstream Products

• 916051-81-5 (5Z)-2-{[2-chloro-5-(1H-tetrazol-5-yl)phenyl]amino}-5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one 

Relevant articles and documents

Anchoring of Cu (II)-Schiff base complex on magnetic mesoporous silica nanoparticles: catalytic efficacy in one-pot synthesis of 5-substituted-1H-tetrazoles, antibacterial activity evaluation and immobilization of α-amylase

Magnetic mesoporous silica nanocomposite, Fe3O4?MCM-41, was prepared and functionalized with N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAPS). Then Schiff base grafted nanoparticles were synthesized by the condensation of 5,5'-

5-Aryltetrazole Compounds, compositions thereof, and uses therefor

The present invention relates to 5-Aryltetrazole compounds, compositions comprising a 5-Aryltetrazole compound, and methods for treating an inflammation disease, a reperfusion disease, hyperuricemia, gout, or tumor-lysis syndrome in an animal in need ther